News | October 02, 2012

Riverain Issued Patents for New Software Cancer Imaging Filters

RiverainClearRead Bone Suppression ClearRead + Detect X-Ray

October 2, 2012 — Riverain Technologies, an industry leader and innovator in proprietary image processing and machine learning technologies, announced that the United States Patent and Trademark Office (USPTO) has awarded the company broad patents for its technologies, opening the door for the company’s software to be used in wider healthcare applications and in other industries. These two new patents not only protect Riverain’s novel chest X-ray technology, which suppresses bone and calls out suspicious tissue, but also hold enormous promise for the company to bring its breakthrough software to other medical applications, including; computed tomography (CT) scans, magnetic resonance imaging (MRI) and ultrasound.

Riverain has been issued U.S. Patent 8,204,292 for its methodology to selectively remove unwanted objects, or features, within images. The technology is used in the company’s premier software, ClearRead Bone Suppression, which suppresses the ribs and clavicles in a chest X-ray image resulting in the formation of a soft tissue image of the chest. The application provides radiologists with a clearer, unobstructed view of the chest to aid in early detection of lung disease, including lung cancer. Currently employed in chest X-ray, a range of possible applications exists within other imaging modalities including CT, MRI, positron emission tomography (PET), full field digital mammography and tomosynthesis. For example, the methodology has been successfully applied to remove and equalize the tissue in the pectoral muscle in a mammography image.

Riverain’s patented feature suppression technology is ideal for use in a variety of industries outside medical as well, including military, travel, industrial and document processing applications.

In addition, Riverain was issued U.S. Patent 8,160,335 for its proprietary computer-aided diagnosis (CAD) methodology on software or hardware derived images, such as dual energy subtracted soft tissue images and/or bone suppressed images. The technology is used in the company’s ClearRead +Detect software, an application that identifies and circles potentially cancerous lung nodules on a bone-suppressed chest X-ray image, and/or images captured by modalities such as dual energy subtraction (DES). ClearRead +Detect has been clinically proven to improve the detection of 9-30mm lung nodules and allow the detection of up to one in two previously missed lung nodules.[1]

“These recently issued patents cover some of the methods and processes that give our market-leading software solutions a distinct advantage,” said Steve Worrell, Riverain’s chief technology officer. “Riverain now has an intellectual property portfolio of more than 15 issued or pending patents and welcomes inquiries regarding applications inside and outside the medical field.”

[1] Riverain Medical OnGuard FDA PMA Reader Study Results 2009

For more information: www.RiverainTechnologies.com

Related Content

FDA Clears Siemens Healthineers' Multix Impact Digital X-ray System
Technology | Digital Radiography (DR) | January 21, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Multix Impact, an affordably priced, floor-mounted digital...
Partners HealthCare Chooses Visage 7 for Enterprise Imaging
News | Enterprise Imaging | January 18, 2019
Visage Imaging Inc. announced the signing of Partners HealthCare, the largest health system in Massachusetts, for...
Seamless Interoperability – Fact or Fiction? This webinar will show how Nemours Children’s Health System adoption of ScImage’s PICOM365 Enterprise PACS  improved workflow. The product will be highlighted at HIMSS 2019.
Sponsored Content | Webinar | PACS | January 17, 2019
This ScImage-sponsored ITN/DAIC webinar will be held at 2 p.m. Eastern time, Wednesday, Feb. 6, 2019.
NewYork-Presbyterian Hospital Partners With Philips for Health IT and Clinical Informatics
News | Enterprise Imaging | January 16, 2019
Philips announced that NewYork-Presbyterian Hospital has chosen to implement the company’s IntelliSpace Enterprise...
AI Approach Outperformed Human Experts in Identifying Cervical Precancer
News | Digital Pathology | January 10, 2019
January 10, 2019 — A research team led by investigators from the National Institutes of Health and Global Good has de
Artificial intelligence, also called deep learning and machine learning, was the hottest topic at the 2018 Radiological Society of North America (RSNA)) meeting.

Artificial intelligence was the hottest topic at the 2018 Radiological Society of North America (RSNA)) meeting, which included a large area with its own presentation therater set asside for AI vendors.

Feature | Artificial Intelligence | January 10, 2019 | Dave Fornell, Editor
Hands down, the hottest topic in radiology the past two years has been the implementation of...
Pacific Northwest VA Network Selects Carestream as Enterprise PACS Supplier
News | PACS | January 08, 2019
Carestream has been awarded a multimillion-dollar healthcare information technology (IT) contract for Veterans Affairs...
Shimadzu Medical Systems USA Acquires Core Medical Imaging
News | Digital Radiography (DR) | January 08, 2019
Shimadzu Medical Systems USA has acquired Core Medical Imaging Inc. (CMI) in order to further expand its healthcare...
Sponsored Content | Videos | Flat Panel Displays | December 25, 2018
EIZO, which means image in Japanese, is a visual technology company that develops and manufactures high-end display s